Profile data is unavailable for this security.
About the company
Lantheus Holdings, Inc. is a radiopharmaceutical-focused company, dedicated to helping clinicians find, fight, and follow disease to deliver better patient outcomes. The Company's product categories include Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships and Others. The Company's Radiopharmaceutical Oncology products help healthcare professionals (HCPs) find, fight and follow cancer. The Company's Precision Diagnostic products assist HCPs to find and follow diseases. Its Strategic Partnerships include biomarkers and digital solutions in support of its partners’ therapeutic development, out-licensing agreements for non-core assets and optimization of its assets geographically. The Company's commercial products are used by cardiologists, internal medicine physicians, neurologists, nuclear medicine physicians, oncologists, radiologists, sonographers, technologists, and urologists working in a variety of clinical settings.
- Revenue in USD (TTM)1.53bn
- Net income in USD167.68m
- Incorporated2007
- Employees808.00
- LocationLantheus Holdings Inc331 Treble Cove RoadNORTH BILLERICA 01862United StatesUSA
- Phone+1 (978) 671-8001
- Fax+1 (302) 636-5454
- Websitehttps://www.lantheus.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Haemonetics Corp | 1.32bn | 175.44m | 2.68bn | 3.02k | 15.87 | 2.97 | 9.32 | 2.04 | 3.64 | 3.64 | 27.40 | 19.46 | 0.525 | 1.58 | 6.47 | 436,081.70 | 6.99 | 5.41 | 8.30 | 6.55 | 59.32 | 53.20 | 13.31 | 9.18 | 1.15 | 12.69 | 0.5733 | 0.00 | 3.95 | 6.60 | 42.64 | 16.99 | 4.37 | -- |
| Integer Holdings Corp | 1.83bn | 87.20m | 3.01bn | 11.00k | 35.84 | 1.72 | 14.25 | 1.64 | 2.40 | 2.39 | 51.76 | 49.83 | 0.5578 | 5.04 | 4.83 | 166,461.30 | 2.66 | 3.28 | 2.84 | 3.54 | 27.15 | 26.70 | 4.76 | 6.38 | 2.45 | 5.23 | 0.4112 | 0.00 | 10.35 | 6.41 | 35.80 | 5.82 | 16.99 | -- |
| ICU Medical Inc | 2.32bn | -7.36m | 3.58bn | 15.00k | -- | 1.68 | 18.25 | 1.54 | -0.3109 | -0.3109 | 94.30 | 86.17 | 0.552 | 2.24 | 12.70 | 154,690.90 | -0.206 | -0.2042 | -0.2351 | -0.2306 | 36.47 | 33.82 | -0.3731 | -0.3326 | 1.19 | 1.62 | 0.3829 | -- | 5.44 | 13.47 | -296.86 | -- | -3.18 | -- |
| LivaNova PLC | 1.35bn | -217.49m | 3.59bn | 2.90k | -- | 3.10 | -- | 2.66 | -4.01 | -4.01 | 24.64 | 21.19 | 0.5311 | 2.58 | 6.60 | 465,159.30 | -8.56 | -4.14 | -11.07 | -5.03 | 68.50 | 67.61 | -16.12 | -9.04 | 1.12 | 10.22 | 0.273 | -- | 8.66 | 2.94 | 260.39 | -- | 10.98 | -- |
| TransMedics Group Inc | 566.35m | 90.47m | 4.44bn | 728.00 | 54.54 | 12.48 | 38.22 | 7.83 | 2.38 | 2.41 | 14.48 | 10.40 | 0.6541 | 4.65 | 6.63 | 777,958.80 | 10.45 | -5.73 | 11.37 | -6.28 | 60.28 | 62.37 | 15.97 | -11.86 | 7.13 | 31.19 | 0.5903 | -- | 82.74 | 79.64 | 241.70 | -- | 279.42 | -- |
| Teleflex Inc | 3.19bn | -327.85m | 4.59bn | 14.10k | -- | 1.20 | -- | 1.44 | -7.35 | -7.36 | 70.55 | 86.48 | 0.4154 | 2.05 | 6.00 | 226,240.30 | -4.27 | 4.58 | -4.69 | 5.01 | 53.67 | 54.77 | -10.28 | 11.38 | 1.53 | 6.78 | 0.4114 | 19.74 | 2.45 | 3.26 | -80.38 | -31.40 | 4.25 | 0.00 |
| Lantheus Holdings Inc | 1.53bn | 167.68m | 4.60bn | 808.00 | 29.14 | 4.11 | 19.81 | 3.02 | 2.38 | 2.38 | 21.90 | 16.88 | 0.7055 | 8.67 | 4.48 | 1,888,531.00 | 7.75 | 9.87 | 10.50 | 11.33 | 62.23 | 60.44 | 10.99 | 12.86 | 2.49 | -- | 0.337 | 0.00 | 18.32 | 34.59 | -4.35 | 58.06 | 29.27 | -- |
| iRhythm Holdings, Inc | 702.57m | -51.46m | 4.65bn | 2.00k | -- | 38.10 | -- | 6.61 | -1.62 | -1.62 | 22.11 | 3.78 | 0.7377 | 12.04 | 9.15 | 351,286.50 | -5.40 | -20.12 | -6.21 | -24.37 | 70.35 | 68.61 | -7.32 | -23.90 | 4.50 | -- | 0.8418 | -- | 20.13 | 22.50 | 8.20 | -- | 19.06 | -- |
| Envista Holdings Corp | 2.72bn | 47.00m | 4.75bn | 12.00k | 105.36 | 1.53 | 29.13 | 1.75 | 0.275 | 0.275 | 16.10 | 18.96 | 0.4931 | 4.62 | 6.86 | 226,625.00 | 0.8523 | -2.14 | 1.01 | -2.58 | 55.02 | 56.70 | 1.73 | -5.21 | 2.04 | 6.70 | 0.318 | -- | 8.32 | 7.11 | 104.20 | 2.03 | -1.03 | -- |
| Stevanato Group SpA | 1.39bn | 166.61m | 4.84bn | 5.52k | 26.19 | 2.56 | 18.22 | 3.49 | 0.6104 | 0.6104 | 5.08 | 6.24 | 0.5058 | 2.95 | 2.65 | 251,208.30 | 6.08 | 8.02 | 7.63 | 10.94 | 29.27 | 31.01 | 12.01 | 13.24 | 1.30 | 30.00 | 0.2386 | 6.82 | 1.72 | 15.53 | -19.13 | 24.61 | 33.52 | -- |
| Merit Medical Systems Inc | 1.48bn | 118.43m | 4.84bn | 7.40k | 41.80 | 3.17 | 19.79 | 3.28 | 1.95 | 1.95 | 24.37 | 25.80 | 0.5898 | 2.39 | 7.38 | 199,611.90 | 4.73 | 3.49 | 5.17 | 3.93 | 48.47 | 45.37 | 8.02 | 5.65 | 2.86 | 14.41 | 0.324 | 0.00 | 7.89 | 6.40 | 27.48 | 85.69 | -14.13 | -- |
| Bruker Corp | 3.44bn | -22.50m | 5.55bn | 11.40k | -- | 2.24 | 27.86 | 1.61 | -0.1487 | -0.1487 | 22.61 | 16.28 | 0.5705 | 1.67 | 5.71 | -- | -0.1212 | 5.07 | -0.155 | 6.76 | 46.70 | 49.41 | -0.2124 | 7.56 | 0.8739 | 7.79 | 0.4268 | 13.13 | 2.08 | 11.57 | -119.89 | -- | 4.34 | 4.56 |
| Caris Life Sciences Inc | -100.00bn | -100.00bn | 5.82bn | -- | -- | 12.16 | -- | -- | -- | -- | -- | 1.70 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 9.36 | -- | 0.4404 | -- | 34.67 | -- | 18.22 | -- | -- | -- |
| Avantor Inc | 6.55bn | -530.20m | 6.27bn | 13.50k | -- | 1.13 | -- | 0.9577 | -0.7775 | -0.7775 | 9.62 | 8.16 | 0.5481 | 5.70 | 6.21 | 485,348.20 | -4.44 | 2.78 | -5.17 | 3.18 | 32.65 | 33.77 | -8.09 | 5.00 | 1.18 | 3.62 | 0.4149 | 0.00 | -3.41 | 0.4913 | -174.52 | -- | 15.90 | -- |
| Glaukos Corp | 469.82m | -87.61m | 6.29bn | 995.00 | -- | 8.16 | -- | 13.38 | -1.55 | -1.55 | 8.28 | 13.41 | 0.4879 | 1.76 | 6.06 | 472,180.90 | -9.10 | -11.24 | -9.92 | -12.04 | 76.87 | 73.54 | -18.65 | -36.68 | 4.47 | -- | 0.0817 | -- | 21.85 | 10.10 | -8.70 | -- | 5.93 | -- |
Data as of Feb 17 2026. Currency figures normalised to Lantheus Holdings Inc's reporting currency: US Dollar USD
52.50%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| BlackRock Fund Advisorsas of 31 Dec 2025 | 7.21m | 10.87% |
| Janus Henderson Investors US LLCas of 30 Sep 2025 | 6.27m | 9.46% |
| The Vanguard Group, Inc.as of 31 Dec 2025 | 6.12m | 9.23% |
| Farallon Capital Management LLCas of 30 Sep 2025 | 3.48m | 5.24% |
| Fidelity Management & Research Co. LLCas of 30 Sep 2025 | 3.10m | 4.68% |
| SSgA Funds Management, Inc.as of 31 Dec 2025 | 2.43m | 3.66% |
| Geode Capital Management LLCas of 31 Dec 2025 | 1.73m | 2.60% |
| Morgan Stanley & Co. LLCas of 31 Dec 2025 | 1.58m | 2.39% |
| Reinhart Partners LLCas of 31 Dec 2025 | 1.56m | 2.36% |
| Dimensional Fund Advisors LPas of 31 Dec 2025 | 1.34m | 2.02% |
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
